Ex Parte Jewson et al - Page 15



          Appeal No. 2006-1750                                        Παγε 15                           
          Application No. 10/435,175                                                                    
          unpersuasive for reasons set forth above, appellants maintain                                 
          that Bowman excludes palladium promoter in a preferred embodiment                             
          leaving little incentive to combine Bowman with Grosch and                                    
          Muller.  We disagree for reasons set forth by the examiner in the                             
          answer (page 11).  In this regard, Grosch teaches that water                                  
          soluble salts should be employed in adding metals, such as gold,                              
          to the catalyst.  See, e.g., column 8, lines 62 through column 9,                             
          line 7 of Grosch.  Nor is the teaching value of Bowman limited to                             
          one preferred embodiment thereof that would exclude palladium.                                
               It follows that, on this record, we affirm the examiner’s                                
          separate obviousness rejection of claim 17.                                                   





                                                                                                       
                                      CONCLUSION                                                        
               The decision of the examiner to reject claims 12-16 and 18                               
          under 35 U.S.C. § 103(a) as being unpatentable over Grosch in                                 
          view of Muller and to reject claim 17 under 35 U.S.C. § 103(a) as                             
          being unpatentable over Grosch in view of Muller and Bowman is                                
          affirmed.                                                                                     














Page:  Previous  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  Next 

Last modified: November 3, 2007